Literature DB >> 3427267

Spironolactone inhibition of contraction and calcium channels in rat portal vein.

C Dacquet1, G Loirand, C Mironneau, J Mironneau, P Pacaud.   

Abstract

1. The effects of spironolactone have been studied on the mechanical activity of rat portal vein strips and the calcium channel currents of isolated cells using the patch clamp technique (whole-cell configuration). 2. Spironolactone (50 nM to 0.1 mM) depressed both K+-induced and twitch contractions within 5-6 min. This inhibitory effect was overcome by elevating the calcium concentration in the perfusing solution. 3. Spironolactone (60 microM) depressed the transient contractions induced in a Ca2+-free, EGTA-containing solution by either acetylcholine (0.1 mM) or noradrenaline (10 microM). The effect of spironolactone was dependent on a reduction in the filling of the internal calcium store. 4. Rapidly inactivating calcium channel current was maintained in the presence of spironolactone (60 microM), while slowly inactivating calcium channel current was blocked in a concentration-dependent manner. Half-inhibition of slow calcium channel current was obtained at concentrations between 5-7 microM. 5. Administration of spironolactone (10 microM) at rest reduced calcium channel current by about 70% (tonic inhibition). Repetitive depolarizations (300 ms long pulses to zero mV, applied between 0.05 and 0.5 Hz) had no further inhibitory effect on the inward current (absence of use-dependence). 6. When cells were held at depolarized membrane potentials at which slow calcium current was inactivated by about 80%, the inhibitory effect of spironolactone (10 microM) was similar to that obtained with cells normally polarized. Spironolactone (10 microM) had no effect on the voltage-dependence of inactivation of the calcium channel current. 7. Our results suggest that spironolactone acts primarily on the plasma membrane by depressing inward current through slow calcium channels. This effect may be explained by a preferential binding of the drug to the resting state of the slow calcium channel. In addition, spironolactone may depress contractions dependent on the release of calcium from the sarcoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3427267      PMCID: PMC1853690          DOI: 10.1111/j.1476-5381.1987.tb11354.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

Review 1.  Mechanisms of action of transmitters and other substances on smooth muscle.

Authors:  T B Bolton
Journal:  Physiol Rev       Date:  1979-07       Impact factor: 37.312

2.  President's page: how to persuade the U.S. Congress to appropriate more money for heart research.

Authors:  B Surawicz
Journal:  Am J Cardiol       Date:  1979-08       Impact factor: 2.778

3.  Effect of a spirolactone derivative, sodium canrenoate, on mechanical and electrical activities of isolated rat myocardium.

Authors:  E Coraboeuf; E Deroubaix
Journal:  J Pharmacol Exp Ther       Date:  1974-10       Impact factor: 4.030

4.  Cat ventricular muscle treated with D600: characteristics of calcium channel block and unblock.

Authors:  T F McDonald; D Pelzer; W Trautwein
Journal:  J Physiol       Date:  1984-07       Impact factor: 5.182

5.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

6.  Comparison of pinaverium bromide, manganese chloride and D600 effects on electrical and mechanical activities in rat uterine smooth muscle.

Authors:  J Mironneau; C Lalanne; C Mironneau; J P Savineau; J L Lavie
Journal:  Eur J Pharmacol       Date:  1984-02-10       Impact factor: 4.432

7.  Effects of noradrenaline and acetylcholine on electro-mechanical properties of the guinea-pig portal vein.

Authors:  T Nanjo
Journal:  Br J Pharmacol       Date:  1984-03       Impact factor: 8.739

8.  Effects of calcium entry blockers on calcium-dependent contractions of rat portal vein.

Authors:  C Dacquet; C Mironneau; J Mironneau
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

9.  Action of indapamide on excitation-contraction coupling in vascular smooth muscle.

Authors:  J Mironneau; Y M Gargouil
Journal:  Eur J Pharmacol       Date:  1979-07-15       Impact factor: 4.432

10.  Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells.

Authors:  K S Lee; R W Tsien
Journal:  Nature       Date:  1983-04-28       Impact factor: 49.962

View more
  7 in total

1.  Chronic splanchnic hemodynamic effects of spironolactone with unrestricted sodium diet in patients with compensated cirrhosis.

Authors:  S Sugano; T Kawafune; T Okajima; K Ishii; M Watanabe; N Takamura
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

2.  Effects of 2,3-butanedione monoxime on whole-cell Ca2+ channel currents in single cells of the guinea-pig taenia caeci.

Authors:  R J Lang; R J Paul
Journal:  J Physiol       Date:  1991-02       Impact factor: 5.182

3.  Pharmacological block of Ca(2+)-activated Cl- current in rat vascular smooth muscle cells in short-term primary culture.

Authors:  A Baron; P Pacaud; G Loirand; C Mironneau; J Mironneau
Journal:  Pflugers Arch       Date:  1991-12       Impact factor: 3.657

4.  The negative inotropic action of canrenone is mediated by L-type calcium current blockade and reduced intracellular calcium transients.

Authors:  A R Costa; L B Torres; E Medei; R A Ricardo; J P França; S Smaili; J H M Nascimento; M E M Oshiro; J W M Bassani; A T Ferreira; P J F Tucci
Journal:  Br J Pharmacol       Date:  2009-08-06       Impact factor: 8.739

5.  Spironolactone and its main metabolite canrenoic acid block hKv1.5, Kv4.3 and Kv7.1 + minK channels.

Authors:  Ricardo Gómez; Lucía Núñez; Ricardo Caballero; Miguel Vaquero; Juan Tamargo; Eva Delpón
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

6.  Interactions of spironolactone with (+)-[3H]-isradipine and (-)-[3H]-desmethoxyverapamil binding sites in vascular smooth muscle.

Authors:  J Mironneau; I Sayet; L Rakotoarisoa; C Dacquet; C Mironneau
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

7.  Fenoverine inhibition of calcium channel currents in single smooth muscle cells from rat portal vein and myometrium.

Authors:  J Mironneau; S Arnaudeau; C Mironneau
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.